Afasevikumab Biosimilar – Anti-IL17A , IL17F mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb - Research Grade |
|---|---|
| Source | CAS 1589503-30-9 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Afasevikumab,MCAF-5352A,NI-1401,RG-7624,RO5553110,IL17A , IL17F,anti-IL17A , IL17F |
| Reference | PX-TA1401 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
General information on Anti-IL17A /IL17F[Homo sapiens] (Afasevikumab) Monoclonal Antibody
Afasevikumab is a monoclonal antibody that targets IL17 and is investigated for the treatment of Multiple Sclerosis(MS).
SDS-PAGE for Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb
Afasevikumab Biosimilar - Anti-IL17A , IL17F mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 95%.
Related products
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
PTX17885-100
180€
SIL
Stable Istotope Labelled Afasevikumab Biosimilar – Anti-IL17A /IL17F mAb – Research Grade
PX-TA1401-SIL
1500€
ELISA
Afasevikumab ELISA Kit
KPTX257
1300€
Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.